Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-25-119836
Filing Date
2025-05-14
Accepted
2025-05-14 16:05:44
Documents
19
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d915186d10ka.htm   iXBRL 10-K/A 217680
2 EX-4.5 d915186dex45.htm EX-4.5 220123
3 EX-31.1 d915186dex311.htm EX-31.1 4108
4 EX-31.2 d915186dex312.htm EX-31.2 4080
  Complete submission text file 0001193125-25-119836.txt   768138

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20241231.xsd EX-101.SCH 5331
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dbvt-20241231_cal.xml EX-101.CAL 957
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20241231_def.xml EX-101.DEF 21326
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20241231_lab.xml EX-101.LAB 28832
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20241231_pre.xml EX-101.PRE 22815
21 EXTRACTED XBRL INSTANCE DOCUMENT d915186d10ka_htm.xml XML 11801
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36697 | Film No.: 25945342
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)